Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers (Q44332720)

2 December 2017

title

Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers (English)

1 reference

2 December 2017

0 references

0 references

1

Margaret Haney

1 reference

2 December 2017

language of work or name

English

0 references

publication date

8 November 2006

1 reference

2 December 2017

published in

Neuropsychopharmacology

1 reference

2 December 2017

volume

32

1 reference

2 December 2017

issue

6

1 reference

2 December 2017

page(s)

1391-1403

1 reference

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

THC does not affect striatal dopamine release: Microdialysis in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Effects of an alternative reinforcer on intravenous heroin self-administration by humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

delta 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

The role of dopamine in drug abuse viewed from the perspective of its role in motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

GABA receptor-linked chloride channels and the behavioral effects of naltrexone in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Treatment of heroin (diamorphine) addiction: current approaches and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Interaction between naltrexone and oral THC in heavy marijuana smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Abstinence symptoms following smoked marijuana in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Effects of acute marijuana smoking on pulse rate and mood states in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Marijuana and cannabinoid regulation of brain reward circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Pharmacological and biochemical interactions between opioids and cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Signaling pathways involved in the development of cannabinoid tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

A diminution of delta9-tetrahydrocannabinol modulation of dynorphin A-(1-17) in conjunction with tolerance development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Transdermal nicotine alters some of marihuana's effects in male and female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Sex-dependent effects of delta 9-tetrahydrocannabinol on locomotor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

Effect of fluoxetine on food intake of humans living in a residential laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Morphine and delta 9-tetrahydrocannabinol: tolerance to the stimulus effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301243

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301243

1 reference

2 December 2017

1 reference